A placebo-controlled, randomized trial of eszopiclone for the treatment of bupropion and abstinence related insomnia during smoking cessation.

Trial Profile

A placebo-controlled, randomized trial of eszopiclone for the treatment of bupropion and abstinence related insomnia during smoking cessation.

Discontinued
Phase of Trial: Phase IV

Latest Information Update: 09 Mar 2012

At a glance

  • Drugs Bupropion; Eszopiclone
  • Indications Insomnia
  • Focus Therapeutic Use
  • Most Recent Events

    • 19 Jan 2009 Planned patient numbers amended from 40 to 4 as reported by ClinicalTrials.gov.
    • 19 Jan 2009 Status changed from recruiting to discontinued as reported by ClinicalTrials.gov.
    • 24 Aug 2007 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top